InvestorsHub Logo
Followers 6
Posts 1400
Boards Moderated 0
Alias Born 08/24/2014

Re: bradrad post# 42740

Thursday, 01/11/2018 2:50:18 PM

Thursday, January 11, 2018 2:50:18 PM

Post# of 48316
The move today is more likely related to the Shareholder meeting happening tomorrow and all the possible trial announcements happening in 2018. PISCES data, collaborations/licensing deals related to the new trials. Will trials be solely with Merck or other Pharmas involved. Possible multi-gene construct collaboration announcement. A lot is going to be happening in 2018. Announcement of the new TNBC trial even before the pilot TNBC data has been released is very Bullish. 2018 I think is only going to be the beginning of great things to come for Oncosec.